Agios Pharmaceuticals (AGIO) Earnings Date & Reports

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AGIO is expected to report earnings to rise 23.61% to -177 cents per share on May 01

Agios Pharmaceuticals AGIO Stock Earnings Reports

Q1'25

Est.

$-1.78

Q4'24

Beat

by $0.24

Q3'24

Beat

by $1.00

Q2'24

Missed

by $0.09

Q1'24

Beat

by $0.19

The last earnings report on February 13 showed earnings per share of -144 cents, beating the estimate of -167 cents. With 329.28K shares outstanding, the current market capitalization sits at 1.51B.

View a ticker or compare two or three

Compare

AGIO